Skip to navigation menu Skip to content
Clinical Trial Search block Test

Expanded Access Protocol of Apitegromab for Patients With Spinal Muscular Atrophy

Apitegromab EAP

What is the goal of the study?

Provide apitegromab to patients prior to FDA approval.

Who can participate in the study?

Non-ambulatory patients 2 years or older with Spinal Muscular Atrophy

Study Team: